Download PDF
Clin Colon Rectal Surg 2010; 23(3): 209-220
DOI: 10.1055/s-0030-1263062
© Thieme Medical Publishers

Complications of Enterocutaneous Fistulas and Their Management

Lara J. Williams1 , Shahram Zolfaghari1 , Robin P. Boushey1
  • 1Department of Surgery, University of Ottawa, Ottawa, Ontario, Canada
Further Information

Publication History

Publication Date:
24 August 2010 (online)

    Permissions and Reprints

ABSTRACT

Complications related to enterocutaneous fistulas are common and include sepsis, malnutrition, and fluid or electrolyte abnormalities. Intestinal failure is one of the most feared complications of enterocutaneous fistula management and results in significant patient morbidity and mortality. The authors review emerging trends in the medical and surgical management of patients with intestinal failure.

KEYWORDS

Enterocutaneous fistula - intestinal failure - short bowel syndrome - intestinal transplantation

REFERENCES

  • 1 Lloyd D A, Gabe S M, Windsor A C. Nutrition and management of enterocutaneous fistula.  Br J Surg. 2006;  93(9) 1045-1055
    CrossrefPubMedGoogle Scholar
  • 2 Campos A C, Andrade D F, Campos G M, Matias J E, Coelho J C. A multivariate model to determine prognostic factors in gastrointestinal fistulas.  J Am Coll Surg. 1999;  188(5) 483-490
    CrossrefPubMedGoogle Scholar
  • 3 Edmunds Jr L H, Williams G M, Welch C E. External fistulas arising from the gastro-intestinal tract.  Ann Surg. 1960;  152 445-471
    CrossrefPubMedGoogle Scholar
  • 4 Evenson A R, Fischer J E. Current management of enterocutaneous fistula.  J Gastrointest Surg. 2006;  10(3) 455-464
    CrossrefPubMedGoogle Scholar
  • 5 Goulet O, Ruemmele F. Causes and management of intestinal failure in children.  Gastroenterology. 2006;  130(2, Suppl 1) S16-S28
    CrossrefPubMedGoogle Scholar
  • 6 Nightingale J M. The medical management of intestinal failure: methods to reduce the severity.  Proc Nutr Soc. 2003;  62(3) 703-710
    CrossrefPubMedGoogle Scholar
  • 7 Carlson G L. Surgical management of intestinal failure.  Proc Nutr Soc. 2003;  62(3) 711-718
    CrossrefPubMedGoogle Scholar
  • 8 Scott N A, Leinhardt D J, O'Hanrahan T, Finnegan S, Shaffer J L, Irving M H. Spectrum of intestinal failure in a specialised unit.  Lancet. 1991;  337(8739) 471-473
    CrossrefPubMedGoogle Scholar
  • 9 Jackson C, Buchman A L. Advances in the management of short bowel syndrome.  Curr Gastroenterol Rep. 2005;  7(5) 373-378
    CrossrefPubMedGoogle Scholar
  • 10 Nightingale J, Woodward J M. Small Bowel and Nutrition Committee of the British Society of Gastroenterology . Guidelines for management of patients with a short bowel.  Gut. 2006;  55(Suppl 4) iv1-iv12
    CrossrefPubMedGoogle Scholar
  • 11 Buchman A L, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation.  Gastroenterology. 2003;  124(4) 1111-1134
    PubMedGoogle Scholar
  • 12 Bines J E. Intestinal failure: a new era in clinical management.  J Gastroenterol Hepatol. 2009;  24(Suppl 3) S86-S92
    CrossrefPubMedGoogle Scholar
  • 13 Slater R. Nutritional management of enterocutaneous fistulas.  Br J Nurs. 2009;  18(4) 225-230
    PubMedGoogle Scholar
  • 14 Carbonnel F, Cosnes J, Chevret S et al.. The role of anatomic factors in nutritional autonomy after extensive small bowel resection.  JPEN J Parenter Enteral Nutr. 1996;  20 275-280
    CrossrefPubMedGoogle Scholar
  • 15 Nightingale J M, Bartram C I, Lennard-Jones J E. Length of residual small bowel after partial resection: correlation between radiographic and surgical measurements.  Gastrointest Radiol. 1991;  16(4) 305-306
    CrossrefPubMedGoogle Scholar
  • 16 Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans.  Gastroenterology. 2000;  119(6) 1496-1505
    CrossrefPubMedGoogle Scholar
  • 17 Jianfeng G, Weiming Z, Ning L et al.. Serum citrulline is a simple quantitative marker for small intestinal enterocytes mass and absorption function in short bowel patients.  J Surg Res. 2005;  127(2) 177-182
    CrossrefPubMedGoogle Scholar
  • 18 Misiakos E P, Macheras A, Kapetanakis T, Liakakos T. Short bowel syndrome: current medical and surgical trends.  J Clin Gastroenterol. 2007;  41(1) 5-18
    CrossrefPubMedGoogle Scholar
  • 19 Williams N S, Evans P, King R F. Gastric acid secretion and gastrin production in the short bowel syndrome.  Gut. 1985;  26(9) 914-919
    CrossrefPubMedGoogle Scholar
  • 20 Windsor C WO, Fejfar J, Woodward D AK. Gastric secretion after massive small bowel resection.  Gut. 1969;  10(10) 779-786
    CrossrefPubMedGoogle Scholar
  • 21 Nightingale J M, Kamm M A, van der Sijp J R, Ghatei M A, Bloom S R, Lennard-Jones J E. Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the ‘colonic brake’ to gastric emptying.  Gut. 1996;  39(2) 267-272
    CrossrefPubMedGoogle Scholar
  • 22 Nightingale J M, Lennard-Jones J E, Walker E R, Farthing M J. Jejunal efflux in short bowel syndrome.  Lancet. 1990;  336(8718) 765-768
    CrossrefPubMedGoogle Scholar
  • 23 Hanna S, MacINTYRE I. The influence of aldosterone on magnesium metabolism.  Lancet. 1960;  2(7146) 348-350
    PubMedGoogle Scholar
  • 24 Edes T E, Walk B E, Thornton Jr W H, Fritsche K L. Essential fatty acid sufficiency does not preclude fat-soluble-vitamin deficiency in short-bowel syndrome.  Am J Clin Nutr. 1991;  53(2) 499-502
    PubMedGoogle Scholar
  • 25 Booth C C, Moulin D L. The site of absorption of vitamin B12 in man.  Lancet. 1959;  i 18-21
    PubMedGoogle Scholar
  • 26 Booth C C, Alldis D, Read A E. Studies on the site of fat absorption: 2. Fat balances after resection of varying amounts of the small intestine in man.  Gut. 1961;  2(2) 168-174
    CrossrefPubMedGoogle Scholar
  • 27 Ammon H V, Phillips S F. Inhibition of colonic water and electrolyte absorption by fatty acids in man.  Gastroenterology. 1973;  65(5) 744-749
    PubMedGoogle Scholar
  • 28 Knapp H R, Melly M A. Bactericidal effects of polyunsaturated fatty acids.  J Infect Dis. 1986;  154(1) 84-94
    CrossrefPubMedGoogle Scholar
  • 29 Earnest D L, Johnson G, Williams H E, Admirand W H. Hyperoxaluria in patients with ileal resection: an abnormality in dietary oxalate absorption.  Gastroenterology. 1974;  66(6) 1114-1122
    PubMedGoogle Scholar
  • 30 Nightingale J M, Lennard-Jones J E, Gertner D J, Wood S R, Bartram C I. Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel.  Gut. 1992;  33(11) 1493-1497
    CrossrefPubMedGoogle Scholar
  • 31 Gracey M. The contaminated small bowel syndrome: pathogenesis, diagnosis, and treatment.  Am J Clin Nutr. 1979;  32(1) 234-243
    PubMedGoogle Scholar
  • 32 Goodland R A, Nightingale J M, Playford R J. Intestinal adaptation. In: Nightingale JM Intestinal Failure. Greenwich; Greenwich Medical Media Limited 2001: 243-260
    PubMedGoogle Scholar
  • 33 Crenn P, Morin M C, Joly F, Penven S, Thuillier F, Messing B. Net digestive absorption and adaptive hyperphagia in adult short bowel patients.  Gut. 2004;  53(9) 1279-1286
    CrossrefPubMedGoogle Scholar
  • 34 Hanson W R, Osborne J W, Sharp J G. Compensation by the residual intestine after intestinal resection in the rat. I. Influence of amount of tissue removed.  Gastroenterology. 1977;  72 692-700
    PubMedGoogle Scholar
  • 35 Doldi S B. Intestinal adaptation following jejuno-ileal bypass.  Clin Nutr. 1991;  10(3) 138-145
    CrossrefPubMedGoogle Scholar
  • 36 Dowling R H, Booth C C. Functional compensation after small-bowel resection in man. Demonstration by direct measurement.  Lancet. 1966;  2(7455) 146-147
    PubMedGoogle Scholar
  • 37 Cisler J J, Buchman A L. Intestinal adaptation in short bowel syndrome.  J Investig Med. 2005;  53(8) 402-413
    CrossrefPubMedGoogle Scholar
  • 38 Platell C F, Coster J, McCauley R D, Hall J C. The management of patients with the short bowel syndrome.  World J Gastroenterol. 2002;  8(1) 13-20
    PubMedGoogle Scholar
  • 39 Jeppesen P B, Mortensen P B. Experimental approaches: dietary and hormone therapy.  Best Pract Res Clin Gastroenterol. 2003;  17(6) 1041-1054
    CrossrefPubMedGoogle Scholar
  • 40 Goulet O, Joly F, Corriol O, Colomb-Jung V. Some new insights in intestinal failure-associated liver disease.  Curr Opin Organ Transplant. 2009;  14(3) 256-261
    CrossrefPubMedGoogle Scholar
  • 41 Gura K M, Lee S, Valim C et al.. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.  Pediatrics. 2008;  121(3) e678-e686
    CrossrefPubMedGoogle Scholar
  • 42 Mertes N, Grimm H, Fürst P, Stehle P. Safety and efficacy of a new parenteral lipid emulsion (SMOFlipid) in surgical patients: a randomized, double-blind, multicenter study.  Ann Nutr Metab. 2006;  50(3) 253-259
    CrossrefPubMedGoogle Scholar
  • 43 Vantini I, Benini L, Bonfante F et al.. Survival rate and prognostic factors in patients with intestinal failure.  Dig Liver Dis. 2004;  36(1) 46-55
    CrossrefPubMedGoogle Scholar
  • 44 Freshwater D A, Saadeddin A, Deel-Smith P, Digger T, Jones B J. Can home parenteral nutrition be provided by non-specialised centres? 2300 weeks of experience at a district general hospital in the United Kingdom.  Clin Nutr. 2005;  24(2) 229-235
    CrossrefPubMedGoogle Scholar
  • 45 Sudan D. Advances in the nontransplant medical and surgical management of intestinal failure.  Curr Opin Organ Transplant. 2009;  14(3) 274-279
    CrossrefPubMedGoogle Scholar
  • 46 Messing B, Bories C, Kunstlinger F, Bernier J J. Does total parenteral nutrition induce gallbladder sludge formation and lithiasis?.  Gastroenterology. 1983;  84(5 Pt 1) 1012-1019
    PubMedGoogle Scholar
  • 47 DeLegge M, Alsolaiman M M, Barbour E, Bassas S, Siddiqi M F, Moore N M. Short bowel syndrome: parenteral nutrition versus intestinal transplantation. Where are we today?.  Dig Dis Sci. 2007;  52(4) 876-892
    CrossrefPubMedGoogle Scholar
  • 48 Sitzmann J V, Pitt H A, Steinborn P A, Pasha Z R, Sanders R C. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans.  Surg Gynecol Obstet. 1990;  170(1) 25-31
    PubMedGoogle Scholar
  • 49 Briones E R, Iber F L. Liver and biliary tract changes and injury associated with total parenteral nutrition: pathogenesis and prevention.  J Am Coll Nutr. 1995;  14(3) 219-228
    PubMedGoogle Scholar
  • 50 Stanko R T, Nathan G, Mendelow H, Adibi S A. Development of hepatic cholestasis and fibrosis in patients with massive loss of intestine supported by prolonged parenteral nutrition.  Gastroenterology. 1987;  92(1) 197-202
    CrossrefPubMedGoogle Scholar
  • 51 Buchman A, Ament M, Sohel M et al.. Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human choline requirement: a placebo-controlled trial.  JPEN J Parenter Enteral Nutr. 2001;  25 260-268
    CrossrefPubMedGoogle Scholar
  • 52 Chan S, McCowen K C, Bistrian B R et al.. Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition.  Surgery. 1999;  126(1) 28-34
    CrossrefPubMedGoogle Scholar
  • 53 Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure.  Ann Intern Med. 2000;  132(7) 525-532
    PubMedGoogle Scholar
  • 54 Oley Foundation .North American home parenteral and enteral nutrition patient registry and annual report. Albany, NY; Oley Foundation 1994
    PubMedGoogle Scholar
  • 55 Messing B, Crenn P, Beau P, Boutron-Ruault M C, Rambaud J C, Matuchansky C. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome.  Gastroenterology. 1999;  117(5) 1043-1050
    CrossrefPubMedGoogle Scholar
  • 56 Beers T, Burnes J, Fleming C. Superior vena caval obstruction in patients with gut failure receiving home parenteral nutrition.  JPEN J Parenter Enteral Nutr.. 1990;  14 474-479
    CrossrefPubMedGoogle Scholar
  • 57 Dollery C M, Sullivan I D, Bauraind O, Bull C, Milla P J. Thrombosis and embolism in long-term central venous access for parenteral nutrition.  Lancet. 1994;  344(8929) 1043-1045
    CrossrefPubMedGoogle Scholar
  • 58 Levy E, Frileux P, Sandrucci S et al.. Continuous enteral nutrition during the early adaptive stage of the short bowel syndrome.  Br J Surg. 1988;  75(6) 549-553
    CrossrefPubMedGoogle Scholar
  • 59 McIntyre P B, Fitchew M, Lennard-Jones J E. Patients with a high jejunostomy do not need a special diet.  Gastroenterology. 1986;  91(1) 25-33
    PubMedGoogle Scholar
  • 60 Cosnes J, Evard D, Beaugerie L, Gendre J P, Le Quintrec Y. Improvement in protein absorption with a small-peptide-based diet in patients with high jejunostomy.  Nutrition. 1992;  8(6) 406-411
    PubMedGoogle Scholar
  • 61 Jeppesen P B, Mortensen P B. Colonic digestion and absorption of energy from carbohydrates and medium-chain fat in small bowel failure.  JPEN J Parenter Enteral Nutr. 1999;  23(5, Suppl) S101-S105
    CrossrefPubMedGoogle Scholar
  • 62 Mayne A J, Handy D J, Preece M A, George R H, Booth I W. Dietary management of D-lactic acidosis in short bowel syndrome.  Arch Dis Child. 1990;  65(2) 229-231
    CrossrefPubMedGoogle Scholar
  • 63 Nightingale J M. Management of patients with a short bowel.  Nutrition. 1999;  15(7–8) 633-637
    CrossrefPubMedGoogle Scholar
  • 64 Jeppesen P B, Mortensen P B. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection.  Gut. 1998;  43(4) 478-483
    CrossrefPubMedGoogle Scholar
  • 65 Sukhotnik I, Mor-Vaknin N, Drongowski R A, Miselevich I, Coran A G, Harmon C M. Effect of dietary fat on early morphological intestinal adaptation in a rat with short bowel syndrome.  Pediatr Surg Int. 2004;  20(6) 419-424
    PubMedGoogle Scholar
  • 66 Ham M, Horton K, Kaunitz J. Fistuloclysis: case report and literature review.  Nutr Clin Pract. 2007;  22(5) 553-557
    CrossrefPubMedGoogle Scholar
  • 67 Teubner A, Morrison K, Ravishankar H R, Anderson I D, Scott N A, Carlson G L. Fistuloclysis can successfully replace parenteral feeding in the nutritional support of patients with enterocutaneous fistula.  Br J Surg. 2004;  91(5) 625-631
    CrossrefPubMedGoogle Scholar
  • 68 Keller J, Panter H, Layer P. Management of the short bowel syndrome after extensive small bowel resection.  Best Pract Res Clin Gastroenterol. 2004;  18(5) 977-992
    PubMedGoogle Scholar
  • 69 Jeppesen P B, Staun M, Tjellesen L, Mortensen P B. Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection.  Gut. 1998;  43(6) 763-769
    CrossrefPubMedGoogle Scholar
  • 70 Nightingale J M, Walker E R, Farthing M J, Lennard-Jones J E. Effect of omeprazole on intestinal output in the short bowel syndrome.  Aliment Pharmacol Ther. 1991;  5(4) 405-412
    CrossrefPubMedGoogle Scholar
  • 71 Nehra V, Camilleri M, Burton D, Oenning L, Kelly D G. An open trial of octreotide long-acting release in the management of short bowel syndrome.  Am J Gastroenterol. 2001;  96(5) 1494-1498
    CrossrefPubMedGoogle Scholar
  • 72 Sukhotnik I, Khateeb K, Krausz M M et al.. Sandostatin impairs postresection intestinal adaptation in a rat model of short bowel syndrome.  Dig Dis Sci. 2002;  47(9) 2095-2102
    CrossrefPubMedGoogle Scholar
  • 73 McDoniel K, Taylor B, Huey W et al.. Use of clonidine to decrease intestinal fluid losses in patients with high-output short-bowel syndrome.  JPEN J Parenter Enteral Nutr. 2004;  28(4) 265-268
    CrossrefPubMedGoogle Scholar
  • 74 Buchmann A L, Wallin A, Fryer J et al.. Clonidine reduces fecal weight and sodium losses modestly in some patients with proximal jejunostomy.  Gastroenterology. 2005;  128(Suppl 2) A-57(399)
    PubMedGoogle Scholar
  • 75 King R F, Norton T, Hill G L. A double-blind crossover study of the effect of loperamide hydrochloride and codeine phosphate on ileostomy output.  Aust N Z J Surg. 1982;  52(2) 121-124
    CrossrefPubMedGoogle Scholar
  • 76 Gruy-Kapral C, Little K H, Fordtran J S, Meziere T L, Hagey L R, Hofmann A F. Conjugated bile acid replacement therapy for short-bowel syndrome.  Gastroenterology. 1999;  116(1) 15-21
    CrossrefPubMedGoogle Scholar
  • 77 Heydorn S, Jeppesen P B, Mortensen P B. Bile acid replacement therapy with cholylsarcosine for short-bowel syndrome.  Scand J Gastroenterol. 1999;  34(8) 818-823
    CrossrefPubMedGoogle Scholar
  • 78 Fürst T, Bott C, Stein J, Dressman J B. Enteric-coated cholylsarcosine microgranules for the treatment of short bowel syndrome.  J Pharm Pharmacol. 2005;  57(1) 53-60
    CrossrefPubMedGoogle Scholar
  • 79 Spagnuolo M I, Iorio R, Vegnente A, Guarino A. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study.  Gastroenterology. 1996;  111(3) 716-719
    CrossrefPubMedGoogle Scholar
  • 80 Byrne T A, Morrissey T B, Nattakom T V, Ziegler T R, Wilmore D W. Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome.  JPEN J Parenter Enteral Nutr. 1995;  19(4) 296-302
    CrossrefPubMedGoogle Scholar
  • 81 Scolapio J S, Camilleri M, Fleming C R et al.. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study.  Gastroenterology. 1997;  113(4) 1074-1081
    CrossrefPubMedGoogle Scholar
  • 82 Ellegård L, Bosaeus I, Nordgren S, Bengtsson B A. Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome.  Ann Surg. 1997;  225(1) 88-96
    CrossrefPubMedGoogle Scholar
  • 83 Szkudlarek J, Jeppesen P B, Mortensen P B. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study.  Gut. 2000;  47(2) 199-205
    CrossrefPubMedGoogle Scholar
  • 84 Seguy D, Vahedi K, Kapel N, Souberbielle J C, Messing B. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study.  Gastroenterology. 2003;  124(2) 293-302
    CrossrefPubMedGoogle Scholar
  • 85 Wallis K, Walters J R, Gabe S. Short bowel syndrome: the role of GLP-2 on improving outcome.  Curr Opin Clin Nutr Metab Care. 2009;  12(5) 526-532
    CrossrefPubMedGoogle Scholar
  • 86 Jeppesen P B, Hartmann B, Thulesen J et al.. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon.  Gastroenterology. 2001;  120(4) 806-815
    CrossrefPubMedGoogle Scholar
  • 87 Jeppesen P B, Sanguinetti E L, Buchman A L et al.. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.  Gut. 2005;  54(9) 1224-1231
    CrossrefPubMedGoogle Scholar
  • 88 O'Keefe S J, Gilroy R, Jeppesen P B et al.. Teduglutide, a novel GLP-2 analog, in the management of short bowel syndrome (SBS) patients dependent on parenteral nutrition: a multicenter, multinational placebo-controlled clinical trial.  Gastroenterology. 2008;  134(4, Suppl 1) A-37
    PubMedGoogle Scholar
  • 89 Falcone Jr R A, Stern L E, Kemp C J, Erwin C R, Warner B W. Intestinal adaptation occurs independent of transforming growth factor-alpha.  J Pediatr Surg. 2000;  35(2) 365-370
    CrossrefPubMedGoogle Scholar
  • 90 Sukhotnik I, Yakirevich E, Coran A G et al.. Effect of transforming growth factor-alpha on intestinal adaptation in a rat model of short bowel syndrome.  J Surg Res. 2002;  108(2) 235-242
    CrossrefPubMedGoogle Scholar
  • 91 Ziegler T R, Mantell M P, Chow J C, Rombeau J L, Smith R J. Intestinal adaptation after extensive small bowel resection: differential changes in growth and insulin-like growth factor system messenger ribonucleic acids in jejunum and ileum.  Endocrinology. 1998;  139(7) 3119-3126
    PubMedGoogle Scholar
  • 92 Chaet M S, Arya G, Ziegler M M, Warner B W. Epidermal growth factor enhances intestinal adaptation after massive small bowel resection.  J Pediatr Surg. 1994;  29(8) 1035-1038, discussion 1038–1039
    CrossrefPubMedGoogle Scholar
  • 93 Johnson W F, DiPalma C R, Ziegler T R, Scully S, Farrell C L. Keratinocyte growth factor enhances early gut adaptation in a rat model of short bowel syndrome.  Vet Surg. 2000;  29(1) 17-27
    CrossrefPubMedGoogle Scholar
  • 94 Wales P W. Surgical therapy for short bowel syndrome.  Pediatr Surg Int. 2004;  20(9) 647-657
    CrossrefPubMedGoogle Scholar
  • 95 Panis Y, Messing B, Rivet P et al.. Segmental reversal of the small bowel as an alternative to intestinal transplantation in patients with short bowel syndrome.  Ann Surg. 1997;  225(4) 401-407
    CrossrefPubMedGoogle Scholar
  • 96 Thompson J S, Langnas A N, Pinch L W, Kaufman S, Quigley E M, Vanderhoof J A. Surgical approach to short-bowel syndrome. Experience in a population of 160 patients.  Ann Surg. 1995;  222(4) 600-605, discussion 605–607
    PubMedGoogle Scholar
  • 97 Brolin R E. Colon interposition for extreme short bowel syndrome: a case report.  Surgery. 1986;  100(3) 576-580
    PubMedGoogle Scholar
  • 98 Devine R M, Kelly K A. Surgical therapy of the short bowel syndrome.  Gastroenterol Clin North Am. 1989;  18(3) 603-618
    PubMedGoogle Scholar
  • 99 Bianchi A. Longitudinal intestinal lengthening and tailoring: results in 20 children.  J R Soc Med. 1997;  90(8) 429-432
    PubMedGoogle Scholar
  • 100 Kim H B, Fauza D, Garza J, Oh J T, Nurko S, Jaksic T. Serial transverse enteroplasty (STEP): a novel bowel lengthening procedure.  J Pediatr Surg. 2003;  38(3) 425-429
    CrossrefPubMedGoogle Scholar
  • 101 Sudan D, Thompson J, Botha J et al.. Comparison of intestinal lengthening procedures for patients with short bowel syndrome.  Ann Surg. 2007;  246(4) 593-601, discussion 601–604
    CrossrefPubMedGoogle Scholar
  • 102 Nishida S, Levi D, Kato T et al.. Ninety-five cases of intestinal transplantation at the University of Miami.  J Gastrointest Surg. 2002;  6(2) 233-239
    CrossrefPubMedGoogle Scholar
  • 103 Fishbein T M, Kaufman S S, Florman S S et al.. Isolated intestinal transplantation: proof of clinical efficacy.  Transplantation. 2003;  76(4) 636-640
    CrossrefPubMedGoogle Scholar
  • 104 Goulet O, Ruemmele F, Lacaille F, Colomb V. Irreversible intestinal failure.  J Pediatr Gastroenterol Nutr. 2004;  38(3) 250-269
    CrossrefPubMedGoogle Scholar
  • 105 Tzakis A G, Kato T, Levi D M et al.. 100 multivisceral transplants at a single center.  Ann Surg. 2005;  242(4) 480-490, discussion 491–493
    PubMedGoogle Scholar
  • 106 Vianna R M, Mangus R S. Present prospects and future perspectives of intestinal and multivisceral transplantation.  Curr Opin Clin Nutr Metab Care. 2009;  12(3) 281-286
    CrossrefPubMedGoogle Scholar
  • 107 Fishbein T M. The current state of intestinal transplantation.  Transplantation. 2004;  78(2) 175-178
    PubMedGoogle Scholar
  • 108 Abu-Elmagd K M. Intestinal transplantation for short bowel syndrome and gastrointestinal failure: current consensus, rewarding outcomes, and practical guidelines.  Gastroenterology. 2006;  130(2, Suppl 1) S132-S137
    CrossrefPubMedGoogle Scholar
  • 109 Vacanti J P. Tissue and organ engineering: can we build intestine and vital organs?.  J Gastrointest Surg. 2003;  7(7) 831-835
    CrossrefPubMedGoogle Scholar
  • 110 Grikscheit T C, Siddique A, Ochoa E R et al.. Tissue-engineered small intestine improves recovery after massive small bowel resection.  Ann Surg. 2004;  240(5) 748-754
    CrossrefPubMedGoogle Scholar
  • 111 Gupta A, Dixit A, Sales K M, Winslet M C, Seifalian A M. Tissue engineering of small intestine—current status.  Biomacromolecules. 2006;  7(10) 2701-2709
    CrossrefPubMedGoogle Scholar
  • 112 Howard L, Heaphey L, Fleming C R, Lininger L, Steiger E. Four years of North American registry home parenteral nutrition outcome data and their implications for patient management.  JPEN J Parenter Enteral Nutr. 1991;  15(4) 384-393
    CrossrefPubMedGoogle Scholar
  • 113 Bakker H, Bozzetti F, Staun M ESPEN-Home Artificial Nutrition Working Group et al. Home parenteral nutrition in adults: a European multicentre survey in 1997.  Clin Nutr. 1999;  18(3) 135-140
    CrossrefPubMedGoogle Scholar
  • 114 Jeppesen P B, Langholz E, Mortensen P B. Quality of life in patients receiving home parenteral nutrition.  Gut. 1999;  44(6) 844-852
    CrossrefPubMedGoogle Scholar

Robin P BousheyM.D. Ph.D. 

Department of Surgery, The Ottawa Hospital General Campus

CCW 1617, 501 Smyth Rd., Ottawa, ON, K1H 8L6, Canada

Email: rboushey@ottawahospital.on.ca

      >